EN
FR
Search for:
Navigation
Services
Preclinical
Clinical
Biotesting
Regulatory
Home
About us
The company
The executive team
The facilities
Our partners
Certifications
Jobs
News & Events
News & Publications
Events
Testimonials
FAQ
Contact
News & Events
>
News & Publications
>
Decrease of Coll2-1 in curcumin exploratory clinical trial
Decrease of a specific biomarker of collagen degradation in osteoarthritis, Coll2-1, by treatment with highly bioavailable curcumin during an exploratory clinical trial
Published on 17/05/2014
Decrease of Coll2-1 in curcumin exploratory clinical trial
This study highlighted the potential effect of curcumin in knee OA patient. This effect was reflected by the variation of a cartilage specific biomarker, Coll2-1 that was rapidly affected by the treatment. These results are encouraging for the qualification of Coll2-1 as a biomarker for the evaluation of curcumin in OA treatment.
PubMed
Our latest news
11/05/2023
Heeft u artrose van de knie?
03/05/2023
Klinisch onderzoek naar spierzwakte
Read more
News & Publications
Events
Testimonials
© Artialis - All rights reserved
Cookie Notice
-
Privacy Policy
Made by